PofoliaShared via Pofolia

Journal of the American Society of Nephrology· 2012Q1

Normal and Pathologic Concentrations of Uremic Toxins

Flore Duranton, Gerald Cohen, Rita De Smet, Mariano Rodríguez et al.

Short summary

A review of 621 articles published since 2003 identified 56 newly reported solutes and updated concentration ranges for 32 known uremic toxins in CKD patients.

AI-generated from the title and abstract; the full text is not read.

Key points

  • Identified 56 newly reported solutes and updated data for 32 known uremic toxins from 87 articles reporting serum/blood measurements in CKD patients.
  • Most frequently reported solutes included β2-microglobulin, indoxyl sulfate, homocysteine, uric acid, and parathyroid hormone.
  • Recent articles report higher uremic concentrations for solutes such as carboxymethyllysine, cystatin C, and parathyroid hormone.
  • Five solutes showed uremic concentrations less than 10% of original reports, and four previously described retention solutes did not exceed normal concentrations.

AI-generated from the title and abstract; the full text is not read.

Abstract

An updated review of the existing knowledge regarding uremic toxins facilitates the design of experimental studies. We performed a literature search and found 621 articles about uremic toxicity published after a 2003 review of this topic. Eighty-seven records provided serum or blood measurements of one or more solutes in patients with CKD. These records described 32 previously known uremic toxins and 56 newly reported solutes. The articles most frequently reported concentrations of β2-microglobulin, indoxyl sulfate, homocysteine, uric acid, and parathyroid hormone. We found most solutes (59%) in only one report. Compared with previous results, more recent articles reported higher uremic concentrations of many solutes, including carboxymethyllysine, cystatin C, and parathyroid hormone. However, five solutes had uremic concentrations less than 10% of the originally reported values. Furthermore, the uremic concentrations of four solutes did not exceed their respective normal concentrations, although they had been previously described as uremic retention solutes. In summary, this review extends the classification of uremic retention solutes and their normal and uremic concentrations, and it should aid the design of experiments to study the biologic effects of these solutes in CKD.

The authors' abstract, as published at the source. Journal of the American Society of Nephrology, 2012 · DOI ↗

TakeawaysPremium
Ask the paperFree account

Continue with a free account

Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.

Continue free on the web

Sign in with Google or Apple; no card needed. You come back to this paper.

On your phone:

Field: Nephrology

NephrologyMedicine